Clinical trial
Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With…
NCT00050674 · Schwartzberg, Lee, M.D., Other · Completed
Key facts
| NCT number | NCT00050674 |
|---|---|
| Title | Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma |
| Official title | Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma |
| Lead sponsor | Schwartzberg, Lee, M.D., Other |
| Collaborators | Amgen Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non-small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Filgrastim-SD/01 |
| Enrollment | 40 |
| Start date | Nov 1, 2001 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Dec 18, 2002 |
| Last update posted | Dec 27, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: